EDITORIAL
REVISTA DE LA FACULTAD DE MEDICINA HUMANA 2020 - Universidad Ricardo Palma
1Instituto de Investigación en Ciencias Biomédicas (INICIB), Universidad Ricardo Palma, Lima-Perú.
2Centro Nacional de Epidemiologia, Prevención y Control de Enfermedades. Ministerio de Salud, Lima-Perú.
3Instituto de Investigaciones Clínicas, Universidad Nacional Mayor de San Marcos, Lima-Perú.
On January 30, 2020, with more than 9,700 confirmed cases in China, the World Health Organization declared the coronavirus outbreak to be a public health emergency of international concern(1). At the end of January, the National Center for Epidemiology, Prevention, and Control of Diseases (CDC-Peru) of the Ministry of Health prepared the “National Plan for Preparation and Response for the Introduction of the coronavirus 2019-nCoV”, where one of the strategic components was to strengthen the epidemiological response through mitigation actions that allow early identification of cases, diagnosis, follow-up of contacts and identification of people with risk conditions(2).
In highly contagious infectious diseases whose treatment is not known and does not have a vaccine, community mitigation measures are the first instance of defense. The objectives are to delay the exponential growth of new cases and shift the epidemic curve to the right, to “buy time”, delay the epidemic peak, allow the preparation of the response and strengthen the supply of health services(3). The CDC-Peru in this mitigation phase activated the Rapid Response Teams (RRTs), which were made up by an epidemiologist from CDC-Peru who performed the identification of cases and the epidemiological investigation in addition to leading the team, a biologist or a medical technologist from the National Institute of Health (INS) who performed the sample collection, and a driver who was in charge of mobilizing the team and ensuring their safety. In this first phase (from the declaration of a pandemic by the WHO to the detection of the SARS-CoV-2 index case), the RRTs were assumed with direct human resources from the CDC-Peru and were in charge of the intervention of cases detected through of epidemiological surveillance, syndromic surveillance, and rumor surveillance.
The second phase began with the detection of the first case, and it was decided to expand the number of RRTs of the CDC-Peru, coordinating the response in a complementary manner with the RRTs of the Direcciones de Redes Integradas de Salud (DIRIS) of Lima, that allowed to expand the coverage for the identification of new cases and to follow up the contacts identified to initiate the epidemiological blockade(4). At the same time, it interacted with the Joint Command of the Armed Forces and the National Police, who joined the RRTs facilitating mobility and drivers, relocating the operations center to the National Stadium, which became the operational point, where they were integrated. teams and intervention activities were conducted. (Figure 1)
Figure 1. Positive cases by diagnostic tests and activities carried out by ERR. 14 May 2020. CDC MINSA.
Correspondencia: Manuel Loayza Alarico.
Dirección: INICB, Facultad de medicina Humana, Edificio I-208. 2do piso. Av. Benavides 5440, Surco, Lima-Perú.
Teléfono: +51 708-0000/ Anexo 6016
Correo electrónico: mloayzaa@yahoo.com